Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.31 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17262624 | 0.77 | MAOB (0.34) | AKR1C3AKR1C2HSD17B1HSD17B2DHODH | |
| SCHEMBL28123521 | 0.75 | NOTUM (0.42) | NOTUMIDO1AKR1C3AKR1C2CYP17A1 | |
| SCHEMBL12472411 | 0.72 | — | — | |
| SCHEMBL6735235 | 0.72 | NOTUM (0.42) | NOTUMIDO1AKR1C3AKR1C2CYP17A1 | |
| SCHEMBL6283639 | 0.71 | — | — | |
| SCHEMBL5798197 | 0.71 | NOTUM (0.35) | NOTUMAKR1C3AKR1C2CYP17A1CYP11B1 | |
| SCHEMBL16564208 | 0.69 | NOTUM (0.34) | NOTUMIDO1AKR1C3AKR1C2CYP17A1 | |
| SCHEMBL2724736 | 0.69 | NOTUM (0.39) | NOTUMIDO1AKR1C3AKR1C2CYP17A1 | |
| SCHEMBL13741967 | 0.68 | CYP17A1 (0.52) | NOTUMIDO1CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL27554718 | 0.68 | IDO1 (0.34) | IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1284626-C | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | EXXONMOBIL CHEM PATENTS INC (US) | 2006-11-15 | — | — | CN | disclosed |
| US-6919291-B2 | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-07-19 | — | — | US | disclosed |
| US-20040110631-A1 | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-06-10 | — | — | US | disclosed |
| CN-1477995-A | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | 埃克森美孚化学专利公司 | 2004-02-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110631-A1 | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | FZD7, FOS, COG4 | NOTUM 213/4885IDO1 2554/4885AKR1C3 2633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.